MMWR Morb Mortal Wkly Rep. 2010 Jun 25;59(24):750.
During January-June 2010, three Enterobacteriaceae isolates carrying a newly described resistance mechanism, the New Delhi metallo-beta-lactamase (NDM-1), were identified from three U.S. states at the CDC antimicrobial susceptibility laboratory. This is the first report of NDM-1 in the United States, and the first report of metallo-beta-lactamase carriage among Enterobacteriaceae in the United States. These isolates, which include an Escherichia coli, Klebsiella pneumoniae, and Enterobacter cloacae, carry blaNDM-1, which confers resistance to all beta-lactam agents except aztreonam (a monobactam antimicrobial); all three isolates were aztreonam resistant, presumably by a different mechanism. In the United Kingdom, where these organisms are increasingly common, carriage of Enterobacteriaceae containing blaNDM-1 has been closely linked to receipt of medical care in India and Pakistan. All three U.S. isolates were from patients who received recent medical care in India.
2010 年 1 月至 6 月期间,在美国疾病预防控制中心抗菌药物敏感性实验室从三个州鉴定出三种携带新描述的耐药机制——新德里金属-β-内酰胺酶(NDM-1)的肠杆菌科分离株。这是美国首次报告 NDM-1,也是美国首次报告肠杆菌科携带金属-β-内酰胺酶。这些分离株包括大肠杆菌、肺炎克雷伯菌和阴沟肠杆菌,携带 blaNDM-1,对除氨曲南(一种单环β-内酰胺类抗生素)以外的所有β-内酰胺类抗生素均具有耐药性;这三种分离株均对氨曲南耐药,推测可能是通过不同的机制。在英国,这些生物体越来越常见,携带 blaNDM-1 的肠杆菌科的传播与在印度和巴基斯坦接受医疗护理密切相关。这三个美国分离株均来自最近在印度接受医疗护理的患者。